ABVC has targeted its business to the stage of drug development that moves promising drugs from the laboratory to the market, the translational phase. Drugs considered by ABVC are usually derived from plants, address significant illnesses, and have successfully completed pre-clinical, disease animal model and Phase I safety studies at world-class research institutions. After examination of the data associated with a new drug c...
ABVC has targeted its business to the stage of drug development that moves promising drugs from the laboratory to the market, the translational phase. Drugs considered by ABVC are usually derived from plants, address significant illnesses, and have successfully completed pre-clinical, disease animal model and Phase I safety studies at world-class research institutions. After examination of the data associated with a new drug candidate, ABVC enters into a licensing agreement with the research institutions, submits an application to the health authorities such as U.S. FDA, Australia TGA and Taiwan TFDA to begin Phase II trials.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.